InChI=1S/C25H44NO7P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-25(28)31-22-24(27)23-33-34(29,30)32-21-20-26/h6-7,9-10,12-13,15-16,24,27H,2-5,8,11,14,17-23,26H2,1H3,(H,29,30)/b7-6-,10-9-,13-12-,16-15-/t24-/m1/s1 |
ROPRRXYVXLDXQO-XSQXPFHXSA-N |
CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)OC[C@@H](O)COP(O)(=O)OCCN |
|
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via lysophosphatidylethanolamine 20:4 )
Escherichia coli metabolite
Any bacterial metabolite produced during a metabolic reaction in Escherichia coli.
(via 1-acyl-sn-glycero-3-phosphoethanolamine )
|
|
(2R)-3-{[(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-hydroxypropyl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate
|
(5Z,8Z,11Z,14Z-eicosatetraenoyl)-lysophosphatidylethanolamine
|
HMDB
|
1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine
|
LIPID MAPS
|
1-arachidonyl-sn-glycero-3-phosphoethanolamine
|
ChEBI
|
1-O-arachidonoyl-sn-glycero-3-phosphoethanolamine
|
ChEBI
|
1-O-arachidonyl-sn-glycero-3-phosphoethanolamine
|
ChEBI
|
LPE(20:4)
|
HMDB
|
LPE(20:4/0:0)
|
HMDB
|
LPE(20:4ω6/0:0)
|
HMDB
|
LysoPE(20:4)
|
HMDB
|
LysoPE(20:4/0:0)
|
HMDB
|
LysoPE(20:4ω6/0:0)
|
HMDB
|
Lysophosphatidylethanolamine(20:4)
|
HMDB
|
Lysophosphatidylethanolamine(20:4/0:0)
|
HMDB
|
PE(20:4(5Z,8Z,11Z,14Z)/0:0)
|
LIPID MAPS
|
PE(20:4/0:0)
|
LIPID MAPS
|